Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
FENNEC PHARMACEUTICALS INC. | Director | Common Shares | 214K | $2.23M | $10.41 | Nov 16, 2023 | Direct |
FENNEC PHARMACEUTICALS INC. | Director | Stock Option | 200K | $1.12M | $5.58 | Aug 15, 2024 | Direct |
Gain Therapeutics, Inc. | Executive Chairman, Director | Common Stock | 881K | $880K | $1.00 | Aug 9, 2024 | Indirect |
Gain Therapeutics, Inc. | Executive Chairman, Director | Common Stock | 50K | $49.9K | $1.00 | Aug 9, 2024 | Direct |
Processa Pharmaceuticals, Inc. | Director | Restricted Stock | 18.2K | Jan 1, 2022 | Direct | ||
Gain Therapeutics, Inc. | Executive Chairman, Director | Stock Option (right to buy) | 15K | Jun 24, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
FENC | FENNEC PHARMACEUTICALS INC. | Aug 15, 2024 | 1 | $140K | 4 | Aug 19, 2024 | Director |
GANX | Gain Therapeutics, Inc. | Aug 9, 2024 | 1 | $49.9K | 4 | Aug 12, 2024 | Executive Chairman, Director |
GANX | Gain Therapeutics, Inc. | Jun 24, 2024 | 1 | $0 | 4 | Jun 26, 2024 | Director |
FENC | FENNEC PHARMACEUTICALS INC. | Nov 16, 2023 | 8 | $0 | 4 | Nov 16, 2023 | Director |
GANX | Gain Therapeutics, Inc. | Jun 23, 2023 | 1 | $0 | 4 | Jun 26, 2023 | Director |
FENC | FENNEC PHARMACEUTICALS INC. | Jun 12, 2023 | 1 | $0 | 4 | Jun 13, 2023 | Director |
GANX | Gain Therapeutics, Inc. | Sep 20, 2022 | 1 | $0 | 4 | Sep 22, 2022 | Director |
FENC | FENNEC PHARMACEUTICALS INC. | Jun 14, 2022 | 1 | $0 | 4 | Jun 16, 2022 | Director |
PCSA | Processa Pharmaceuticals, Inc. | Mar 31, 2022 | 1 | $0 | 4 | Apr 4, 2022 | Director |
PCSA | Processa Pharmaceuticals, Inc. | Mar 15, 2022 | 1 | $0 | 4 | Apr 19, 2022 | Director |
FENC | FENNEC PHARMACEUTICALS INC. | Jun 29, 2021 | 1 | $0 | 4 | Jul 1, 2021 | Director |